Skip to main content

Table 1 Clinicopathological features of our 35 patients diagnosed with GIST

From: The expression of MDM2 in gastrointestinal stromal tumors: immunohistochemical analysis of 35 cases

Cases Age (year) Sex Site Histol type Necrosis Risk Metastatic site MDM2
1 40 F Stomach Sp cel High Peritoneum +
2 53 M Stomach Sp cel High Peritoneum, Liver +
3 65 F Peritoneum Sp + Ep cel + High Liver, lung +
4 42 M Small bowel Sp cel Low
5 40 F Duodenum Sp cel + Intermediate Peritoneum +
6 50 F Small bowel Sp cel Low +
7 35 M Small bowel Sp cel Intermediate
8 84 M Small bowel Sp cel + High Liver +
9 60 M Peritoneum Sp cel High +
10 50 M Duodenum Sp cel Intermediate +
11 43 F Stomach Sp cel + High
12 56 M Small bowel Sp + Ep cel + High Peritoneum +
13 64 F Colon Sp cel Low
14 54 F Stomach Ep cel + High
15 72 M Stomach Sp cel High Peritoneum, liver, lung, adrenal gland +
16 60 F Stomach Sp cel High +
17 52 M Small bowel Sp cel High +
18 70 M Stomach Sp cel Intermediate +
19 55 M Small bowel Sp cel High
20 50 M Stomach Sp + Ep cel High Peritoneum +
21 50 M Stomach Sp cel Very low
22 48 M Duodenum Sp cel Low
23 45 M Stomach Sp + Ep cel + High +
24 83 M Stomach Sp cel High
25 70 M Small bowel Sp cel High Lung, liver
26 25 F Small bowel Sp cel Low
27 70 F Stomach Sp + Ep cel Intermediate
28 49 M Stomach Sp cel Intermediate
29 58 F Peritoneum Sp cel High
30 52 M Stomach Sp cel Intermediate
31 64 M Stomach Sp cel High
32 56 M Peritoneum Sp cel High
33 30 F Peritoneum Sp cel + High
34 57 F Stomach Sp cel Very low
35 37 F Stomach Sp cel High
  1. F female, M male, Sp cel spindle cells type, Sp + Ep cel spindle and epithelioid type, Ep epithelioid type, − absent, negative, + present, positive
\